title: Prostatic intraepithelial neoplasia and prostate cancer.
abstract: Prostatic intraepithelial neoplasia (PIN) is composed of dysplastic cells with a luminal cell phenotype, expressing the androgen receptor as well as prostate specific antigen. PIN is characterized by progressive abnormalities of phenotype which are intermediate between normal prostatic epithelium (NP) and cancer, indicating impairment of cell differentiation and regulatory control with advancing stages of carcinogenesis. High-grade PIN is considered the most likely precursor of prostatic carcinoma (PCa), according to virtually all available evidence. Androgen deprivation decreases the prevalence and extent of PIN and the degree of capillary vascularization (e.g., angiogenesis) in the surrounding stroma via the suppression of vascular endothelial growth factor (VEGF) production. It is likely that PCa might also arise from precursor lesions other than high-grade PIN (low-grade PIN, atypical adenomatous hyperplasia, malignancy-associated foci, and atrophy).
authors.affiliation: Department of Pathology and Laboratory, University of Ancona School of Medicine, Torrette di Ancona, Ancona, Italy. r.m@popcsi.unian.it
authors.forename: R
authors.initials: R
authors.lastname: Montironi
authors.forename: A
authors.initials: A
authors.lastname: Santinelli
authors.forename: R
authors.initials: R
authors.lastname: Mazzucchelli
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018890:Chemoprevention; D006801:Humans; D008297:Male; D019048:Prostatic Intraepithelial Neoplasia / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000517:prevention & control; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000517:prevention & control
chemical_list: D000726:Androgen Antagonists; D000970:Antineoplastic Agents